Clinical trial
Efficacy and Safety of Add-on Topiramate vs Metformin on Cardio-Metabolic Profile in Patients With Schizophrenia on Atypical Antipsychotics With Metabolic Syndrome: a Randomized Controlled Trial
NCT05663749 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences, Bhubaneswar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Add-on Topiramate vs Metformin on Cardio-Metabolic Profile in Patients With Schizophrenia on Atypical Antipsychotics With Metabolic Syndrome: a Randomized Controlled Trial
- Lead sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 20, 2022
- Completion date
- August 20, 2023
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.